Can a gel fight breast cancer? new study tests skin absorption after radiation
NCT ID NCT04009044
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well a medicated gel (afimoxifene) is absorbed through the skin of the breast in women who have had radiation for breast cancer. Researchers want to understand if differences in skin type or past radiation change how much gel gets into the breast tissue. The goal is to learn how to best use this gel to possibly prevent or treat breast cancer in the future. About 156 women who had radiation on one breast will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER SURVIVOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
-
University of Illinois Cancer Center
Chicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fasting during chemo: a new way to boost treatment?
- Exercise as medicine: tailored workouts may rebuild strength after cancer
- Could a common cholesterol drug boost breast cancer treatment?
- Gene test could guide breast cancer treatment to boost survival
- One-Week radiation for breast cancer: MRI precision may cut side effects
- Could a single day of radiation replace weeks of treatment for breast cancer?